Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX® (Cefixime) Capsules 400 mg from the United States Food and Drugs Administration (FDA). Lupin expects to commence shipping the product in the near future
SUPRAX® is currently available as 100 mg/5ml and 200 mg/5ml suspensions as well as 400 mg tablets
http://www.firstwordpharma.com/node/989626
No comments:
Post a Comment